Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
31.20
+0.04 (0.13%)
At close: Dec 5, 2025, 4:00 PM EST
30.69
-0.51 (-1.63%)
After-hours: Dec 5, 2025, 7:56 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.82 billion as of December 5, 2025. Its market cap has increased by 223.61% in one year.
Market Cap
3.82B
Enterprise Value
3.74B
1-Year Change
223.61%
Ranking
Category
Stock Price
$31.20
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.82B, an increase of 388.69%. That is a compound annual growth rate of 31.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.82B | 134.40% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 487.23B |
| AbbVie | 402.93B |
| UnitedHealth Group | 302.60B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.78B |
| Abbott Laboratories | 215.81B |